Inhibiting the action of a particular enzyme dramatically slows the growth of tumor cells tied to BRCA1 and BRCA2 genetic mutations which, in turn, are closely tied to breast and ovarian cancers, according to researchers at NYU Langone Medical Center.
from The Medical News http://ift.tt/16ehi3E
from The Medical News http://ift.tt/16ehi3E
No comments:
Post a Comment